Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001175580 | SCV001339213 | uncertain significance | not specified | 2021-06-28 | criteria provided, single submitter | clinical testing | Variant summary: ALPL c.944_946delTGG (p.Val315del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The variant was absent in 251178 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.944_946delTGG in individuals affected with Hypophosphatasia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Fulgent Genetics, |
RCV002483942 | SCV002790137 | uncertain significance | Adult hypophosphatasia; Childhood hypophosphatasia; Infantile hypophosphatasia | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001828591 | SCV002094080 | uncertain significance | Hypophosphatasia | 2020-11-06 | no assertion criteria provided | clinical testing |